Pharma-Bio Serv, Inc.
PBSV · OTC
10/31/2024 | 10/31/2023 | 10/31/2022 | 10/31/2021 | |
|---|---|---|---|---|
| Market Cap | $13 | $20 | $20 | $24 |
| - Cash | $7 | $10 | $14 | $17 |
| + Debt | $0 | $0 | $0 | $1 |
| Enterprise Value | $7 | $9 | $6 | $8 |
| Revenue | $10 | $17 | $19 | $20 |
| % Growth | -44% | -12.5% | -3.6% | – |
| Gross Profit | $3 | $5 | $5 | $5 |
| % Margin | 26.5% | 29.8% | 25.2% | 26.6% |
| EBITDA | -$1 | $1 | $1 | -$4 |
| % Margin | -11.6% | 7.7% | 6.3% | -18.8% |
| Net Income | -$1 | $1 | $1 | -$2 |
| % Margin | -8.2% | 7.7% | 5.2% | -10.4% |
| EPS Diluted | -0.034 | 0.057 | 0.044 | -0.091 |
| % Growth | -159.5% | 30.4% | 148.2% | – |
| Operating Cash Flow | -$1 | $2 | $1 | $1 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$1 | $2 | $1 | $1 |